-
Conference Date
November 15-17, 2024
-
Abstract Submission Deadline
October 22, 2024
-
Early Online Registration Deadline
October 15, 2024
-
On-Site Registration Date
November 15, 2024
Fu-Dong Shi
Tianjin Medical University General Hospital
Fu-Dong Shi, MD, Ph.D, MAE
Professor and Chairman, Chief Neurologist,
Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China
Division of Neuroimmunology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital of Capital Medical University, Beijing, China
Email: fshi@tmu.edu.cn
Fu-Dong Shi is a neurologist specialized in the management of multiple sclerosis and related disorders. He completed his clinical and research training in Peking Union Hospital, China, Karolinska Institute, Sweden, The Scripps Research Institute, California, and Barrow Neurological Institute, Arizona, USA. He currently serves as Chief of Neuroimmunology Section, Chinese Neurological Association; Board Member European Charcot Foundation; and past Scientific Chair of PACTRIMS. He has published 258 articles, acquired over 20 patents, and serves on Editorial Board of Science Translational Medicine and Cell Death & Differentiation. He has been an elected member of the Academia Europaea in 2024 for distinguished accomplishment in research and care for patients with neuroinflammatory disorders.
Professor and Chairman, Chief Neurologist,
Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China
Division of Neuroimmunology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital of Capital Medical University, Beijing, China
Email: fshi@tmu.edu.cn
Fu-Dong Shi is a neurologist specialized in the management of multiple sclerosis and related disorders. He completed his clinical and research training in Peking Union Hospital, China, Karolinska Institute, Sweden, The Scripps Research Institute, California, and Barrow Neurological Institute, Arizona, USA. He currently serves as Chief of Neuroimmunology Section, Chinese Neurological Association; Board Member European Charcot Foundation; and past Scientific Chair of PACTRIMS. He has published 258 articles, acquired over 20 patents, and serves on Editorial Board of Science Translational Medicine and Cell Death & Differentiation. He has been an elected member of the Academia Europaea in 2024 for distinguished accomplishment in research and care for patients with neuroinflammatory disorders.
Fold
Congress has ended
View on Mobile Devices